Products

Triple Incretin Receptor Agonist targeting GLP-1, GIP, and Glucagon receptors simultaneously for powerful fat loss and metabolic optimization.

Dual GLP-1/GIP Receptor Agonist for advanced weight management and metabolic support with once-weekly dosing.

Semaglutide GLP-1 agonist for effective appetite control and sustainable weight loss.

Long-acting amylin analogue for enhanced satiety, reduced food intake, and sustainable weight management.

Innovative GLP-1/glucagon dual agonist for weight loss, glycemic control, and metabolic disease treatment.

Dual GLP-1/glucagon agonist researched for obesity, MASH, and metabolic liver disease.

Dual-pathway combination of Cagrilintide and Semaglutide for maximum appetite control and sustainable weight loss.

Modified hGH fragment designed for targeted fat loss without impacting blood sugar levels or IGF-1.